Biosynthetic Human Milk Oligosaccharides (HMOs)
Market
Biosynthetic Human Milk Oligosaccharides (HMOs)
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biosynthetic Human Milk Oligosaccharides (HMOs)
Market Size and Growth
The Biosynthetic Human Milk Oligosaccharides (HMOs) market is rapidly expanding, driven by rising demand for infant nutrition and gastrointestinal health products. The market's estimated size reached USD 1.2 billion in 2023, with significant growth anticipated due to advancements in biotechnology and increasing consumer awareness of health benefits associated with HMOs.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Abbott
◍ Dupont (Inbiose)
◍ DSM (Glycom)
◍ Chr. Hansen (Jennewein)
◍ BASF
◍ FrieslandCampina
The Biosynthetic Human Milk Oligosaccharides (HMOs) market features key players like Abbott, DuPont, DSM, Chr. Hansen, BASF, and FrieslandCampina, driving growth through innovative products and research. These companies enhance nutrition in infant formula and promote gut health, significantly contributing to market expansion. Sales revenues vary, with Abbott reporting $43 billion (2022).
Request Sample Report
Market Segmentation
By Application
Infant Formula
Other Applications
Request Sample Report
By Product
2'-FL & 3-FL
LNT & LNnT, etc.
Market Growth
Request Sample Report
$ X Billion USD
